Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


PINL:CTABF - Post by User

Canntab Therapeutics Ltd > PILL on Watch Zone
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by Tonydeon Apr 29, 2018 12:47am
113 Views
Post# 27955264

RE:RE:PILL on Watch Zone

RE:RE:PILL on Watch Zone
I don't think that there is going to be any reverse split for Canntab. With all due respect no one can compare Telferscot with Canntab, (I have to admit, it did hurt to give up 200 of my shares for one (1) New Share). Now that we know that Canntab has the right products, the knowledge and a great team of professionals not only with a vision, but the ability to execute it. With a portfolio that includes, 11 patent applications, and a joint venture agreement with Australia's Queensland Bauxite to manufacture, distribute and sell Canntab's proprietary products, including our famous XR cannabis tablets in Australia and throughout Asia, Emblem's deal and more. In my honest opinion, this time we're on the other side. Other corporations will pay a hefty premium to join us, amalgamate or acquire Canntab. I think that this joint venture will eventually develop in an amalgamation or buyout, one way or the other. I don't hold a doctorate degree, yet I'm pretty sure that the day will come when our Extended Release Tablet (XR) formula will be adapted to other drugs. GLTA.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities